Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001851734-21-000104
Filing Date
2021-11-16
Accepted
2021-11-16 15:19:56
Documents
40
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q quan20210930_10q.htm   iXBRL 10-Q 401084
2 EXHIBIT 31 ex_305054.htm EX-31 8249
3 EXHIBIT 32 ex_305055.htm EX-32 4563
  Complete submission text file 0001851734-21-000104.txt   2135116

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA qtxb-20210930.xsd EX-101.SCH 22614
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qtxb-20210930_cal.xml EX-101.CAL 17160
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qtxb-20210930_def.xml EX-101.DEF 173994
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtxb-20210930_lab.xml EX-101.LAB 137702
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtxb-20210930_pre.xml EX-101.PRE 184830
9 EXTRACTED XBRL INSTANCE DOCUMENT quan20210930_10q_htm.xml XML 180594
Mailing Address P.O. BOX 4960 TUALATIN OR 97062
Business Address P.O. BOX 4960 TUALATIN OR 97062 267-880-1595
QUANTRX BIOMEDICAL CORP (Filer) CIK: 0000820608 (see all company filings)

EIN.: 330202574 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17119 | Film No.: 211415761
SIC: 3841 Surgical & Medical Instruments & Apparatus